Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal.
about
Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterizationAn insight into the sialome of Anopheles funestus reveals an emerging pattern in anopheline salivary protein familiesProteomic Substrate Identification for Membrane Proteases in the BrainDevelopment of a small D-enantiomeric Alzheimer's amyloid-β binding peptide ligand for future in vivo imaging applicationsNatural Products from Microalgae with Potential against Alzheimer's Disease: Sulfolipids Are Potent Glutaminyl Cyclase Inhibitors.Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development.Glutaminyl cyclase knock-out mice exhibit slight hypothyroidism but no hypogonadism: implications for enzyme function and drug developmentIsolation and characterization of the glutaminyl cyclases from Solanum tuberosum and Arabidopsis thaliana: implications for physiological functions.Functional anthology of intrinsic disorder. 3. Ligands, post-translational modifications, and diseases associated with intrinsically disordered proteins.Formation of N-pyroglutamyl peptides from N-Glu and N-Gln precursors in Aplysia neurons.Evidence for N- and C-terminal processing of a plant defense-related enzyme: Primary structure of tobacco prepro-beta-1,3-glucanase.Amino Acids Are an Ineffective Fertilizer for Dunaliella spp. Growth.A major stylar matrix polypeptide (sp41) is a member of the pathogenesis-related proteins superclassAmino acid sequence of the ;pathogenesis-related' leaf protein p14 from viroid-infected tomato reveals a new type of structurally unfamiliar proteins.Prediction of protein modification sites of pyrrolidone carboxylic acid using mRMR feature selection and analysisThe isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions.Oxidative folding and N-terminal cyclization of onconase.Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide.Comparative metabolomics of muscle interstitium fluid in human trapezius myalgia: an in vivo microdialysis studyInhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice.Papaya glutamine cyclotransferase shows a singular five-fold beta-propeller architecture that suggests a novel reaction mechanism.Removal of N-terminal blocking groups from proteins.N-terminal pyroglutamate formation in CX3CL1 is essential for its full biologic activity.Pyroglutamic acid promotes survival of retinal ganglion cells after optic nerve injury.Improving mass accuracy of high performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry of intact antibodies.Sequence analysis of a proteolyzed site in Drosophila choline acetyltransferase.Intrinsic Disorder and Posttranslational Modifications: The Darker Side of the Biological Dark Matter.
P2860
Q24301539-1D1CCBBD-5F8D-41AB-9164-C95F591086F0Q27478299-264B0B7C-A26A-46A3-8767-0B18CE5F3EADQ28069428-89BAC453-44F6-4675-83A6-DE16260F5281Q28728851-B9D780EE-0535-4C27-ABEA-C3B347805E11Q30313757-0C01D8BF-7289-40D2-A156-31FA550FF88DQ30317993-C6210D08-9205-4DA8-8374-D5ADC2D39806Q30318462-42564731-0AA5-4A8A-9892-2B0644157DBFQ30319888-AC1372B4-A06C-4344-BBC0-315C8237DF61Q30360723-48EF728F-8AD4-4976-948D-D577B169EB5AQ31916641-9316053A-C453-484E-A944-2DCD0D9EB7C1Q33635554-5087D8FC-86E4-4BCF-B2B4-EF12C913B260Q33729376-7B56D764-16C4-49AF-8332-7FCA693809FDQ33922410-FD19B7F8-A3A6-4651-918A-35C1C40E59C6Q33931830-378D4656-0858-400C-823A-0B4C04F35873Q34102974-53021E20-D003-4116-B164-C3869BB47067Q36038807-F633EE76-6B5A-4CFD-9600-58211C3E1FF5Q36874127-9026E6C3-DDC1-4458-94F3-014821106F16Q36976659-634D34F2-0F89-4D14-A240-CD85F80FEFBEQ37309640-C2B3F673-1431-4AF9-9F75-58928205DF69Q39170768-B39CD6BF-8C61-46B2-8DA5-30F1FB995AEEQ41451534-7D98DB3B-D954-4E58-B8A5-434FA7F597FDQ42169422-A77A9D8D-DCBB-432A-818B-99D7B8034337Q42373920-54BA2739-89B3-43AD-937E-5D9D856DAD3CQ43245700-0642A7D3-89EB-441C-9E0B-B9891F902814Q46091062-2A46F672-2953-474F-8443-A2AEC7705B3AQ47070157-E3C2839C-5819-4388-B568-F86D05AC2873Q55066708-AAC5A7ED-16EB-4CD9-855D-BEF71C0656F7
P2860
Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Pyroglutamic acid. Non-metabol ...... enzymes effecting its removal.
@en
type
label
Pyroglutamic acid. Non-metabol ...... enzymes effecting its removal.
@en
prefLabel
Pyroglutamic acid. Non-metabol ...... enzymes effecting its removal.
@en
P356
P1476
Pyroglutamic acid. Non-metabol ...... enzymes effecting its removal.
@en
P2093
D N Podell
G N Abraham
P2888
P304
P356
10.1007/BF00235695
P478
38 Spec No
P577
1981-08-01T00:00:00Z
P6179
1015288758